Skip to content

Rogers Corporation ROG Return on equity

Return on equity at other companies

3M logo
3MMMM
72.1%-21.3pp
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-48.9%-498pp
Biogen logo
BiogenBIIB
8%-1.2pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
65%+53.8pp
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-0.2%-0.1pp
Entegris logo
EntegrisENTG
6.8%-1.9pp

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

Based on trailing twelve months.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's return on equity?
Rogers Corporation (ROG) reported return on equity of -4.9% in Q1 2026.
How has Rogers Corporation's return on equity changed year-over-year?
Rogers Corporation's return on equity decreased by 457.2% year-over-year, from 1.4% to -4.9%.
What is the long-term trend for Rogers Corporation's return on equity?
Over 5 years (2020 to 2025), Rogers Corporation's return on equity has grown at a 1.2% compound annual growth rate (CAGR), from 5.1% to -5.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.